Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Chris Lange | Sep 10, 2015 at 2:10 PM EDT

La Jolla Gears Up for Secondary Offering

La Jolla Pharmaceuticals has announced the pricing of an underwritten offering of 2.55 million shares of its common stock.

Jon C. Ogg | Sep 10, 2015 at 10:50 AM EDT

Biogen Follows Gilead With Large Debt Offering

ThinkstockAre biotech companies going to become the next big companies saddled with debt? Most likely not, but two debt offerings…

Chris Lange | Sep 10, 2015 at 7:15 AM EDT

AnaptysBio Gets Ready for IPO

AnaptysBio Inc. has filed with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO).

Chris Lange | Sep 9, 2015 at 12:20 PM EDT

Can Akebia Sustain This Move?

Akebia Therapeutics has had a rough time this year, but shares took a sharp left turn in Wednesday's session on…

Chris Lange | Sep 9, 2015 at 11:25 AM EDT

Penumbra Sets Terms for IPO in New Filing

Penumbra Inc. has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).

Jon C. Ogg | Sep 9, 2015 at 11:10 AM EDT

Why Gilead Faces Unenthusiastic Ratings Into Massive Debt Offering

Gilead Sciences is going to raise cash via a huge debt offering. Will this cash be used to fund a…

Chris Lange | Sep 9, 2015 at 10:50 AM EDT

Can Tetraphase Survive This Implosion?

When investors see a drop of almost 80% in a share price, the question of long-term viability is almost impossible…

Jon C. Ogg | Sep 8, 2015 at 11:40 AM EDT

Is the Huge Jump in Nanosphere Sustainable?

24/7 Wall St. wants to see if Tuesday's move in Nanosphere after an FDA OK is sustainable.

Chris Lange | Sep 5, 2015 at 9:15 AM EDT

5 Top Biotech Stocks That Ran This Past Week

Over the past week, a few biotech companies made absolutely massive runs. Here is information about some of them, as…

Chris Lange | Sep 5, 2015 at 9:05 AM EDT

4 New Big FDA Decisions Expected in September

24/7 Wall St. has collected several big FDA decisions coming up on the calendar for the month of September and…

Chris Lange | Sep 4, 2015 at 11:50 AM EDT

PointClickCare Gears Up for IPO

PointClickCare has filed with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO).

Chris Lange | Sep 4, 2015 at 10:35 AM EDT

Is There Another 25% Upside in Medtronic?

On Medtronic, Oppenheimer has an Outperform rating and a $86 price target, implying upside of 25% from current prices.

Chris Lange | Sep 3, 2015 at 2:05 PM EDT

Why Lannett Is Running

Lannett climbed high on Thursday after announcing the signing of a definitive agreement to purchase UCB's generics unit, Kremers Urban,…

Chris Lange | Sep 3, 2015 at 9:50 AM EDT

Q1 Revenue Lifts Medtronic Over Low Earnings Bar

Medtronic reported lower but better-than-expected fiscal first-quarter earnings before the markets opened on Thursday.

Chris Lange | Sep 2, 2015 at 1:50 PM EDT

Tesaro Rises on Positive FDA Results

Tesaro shares reacted positively in the market Wednesday after positive study results surrounding its lead product were released.

1 … 246 247 248 249 250 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

La Jolla Gears Up for Secondary Offering

Biogen Follows Gilead With Large Debt Offering

AnaptysBio Gets Ready for IPO

Can Akebia Sustain This Move?

Penumbra Sets Terms for IPO in New Filing

Why Gilead Faces Unenthusiastic Ratings Into Massive Debt Offering

Can Tetraphase Survive This Implosion?

Is the Huge Jump in Nanosphere Sustainable?

5 Top Biotech Stocks That Ran This Past Week

4 New Big FDA Decisions Expected in September

PointClickCare Gears Up for IPO

Is There Another 25% Upside in Medtronic?

Why Lannett Is Running

Q1 Revenue Lifts Medtronic Over Low Earnings Bar

Tesaro Rises on Positive FDA Results

Wealthy, Rich, or Upper Class? The retirement numbers at every tier

Bernstein Analyst: AI Agents Drive Chip Demand ‘Off the Charts,’ Supply Can’t Keep Up

Eli Lilly Captures 60% of the GLP-1 Market as Mounjaro Revenue Soars 125%

A Couple With $3.1 Million Disagrees on Whether to Take Social Security at 62 or 70

This health insurer lost 2 million customers — and made $1.5 Billion anyway. Here's how

Wealthy, Rich, or Upper Class? The retirement numbers at every tier

Bernstein Analyst: AI Agents Drive Chip Demand ‘Off the Charts,’ Supply Can’t Keep Up

Health and Healthcare Articles

All Health and Healthcare Articles

La Jolla Gears Up for Secondary Offering

Biogen Follows Gilead With Large Debt Offering

AnaptysBio Gets Ready for IPO

Can Akebia Sustain This Move?

Penumbra Sets Terms for IPO in New Filing

Why Gilead Faces Unenthusiastic Ratings Into Massive Debt Offering

Can Tetraphase Survive This Implosion?

Is the Huge Jump in Nanosphere Sustainable?

5 Top Biotech Stocks That Ran This Past Week

4 New Big FDA Decisions Expected in September

PointClickCare Gears Up for IPO

Is There Another 25% Upside in Medtronic?

Why Lannett Is Running

Q1 Revenue Lifts Medtronic Over Low Earnings Bar

Tesaro Rises on Positive FDA Results

Wealthy, Rich, or Upper Class? The retirement numbers at every tier

Bernstein Analyst: AI Agents Drive Chip Demand ‘Off the Charts,’ Supply Can’t Keep Up

Eli Lilly Captures 60% of the GLP-1 Market as Mounjaro Revenue Soars 125%

Featured Reads

A Couple With $3.1 Million Disagrees on Whether to Take Social Security at 62 or 70

This health insurer lost 2 million customers — and made $1.5 Billion anyway. Here's how